Survival increased in early stage breast cancer after treatment with herceptin and chemo

Treating women with early stage breast cancer with a combination of chemotherapy and the molecularly targeted drug Herceptin significantly increases survival in patients with a specific genetic mutation that results in very aggressive disease, a researcher with UCLA's Jonsson Comprehensive Cancer Center reported Wednesday.

Read the whole article on Physorg

More from Physorg